The popularity of Viagra initially fueled a period of growth for pharma, but recent developments present a uncertain scenario for those considering a stake. Generic alternatives are reducing revenue, and continued https://ineslhek448547.mdkblog.com/47325369/the-blue-pill-and-pharma-a-precarious-investment